Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Badger Meter Inc Reports Strong Financial Results and Promising Outlook for Future Growth

Elaine Mendonca by Elaine Mendonca
January 27, 2024
in Breaking News
0
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Badger Meter, Inc (NYSE:BMI) announced impressive results for the fiscal fourth quarter of 2023, with a notable 24% increase in sales, reaching $182.44 million. This surpassed market expectations by a slight margin. The company’s utility water sales experienced a remarkable 28% year-on-year growth, driven by the high demand for its digital smart water solutions, including cellular AMI and SaaS offerings. This strong performance contributed to a 50 basis point increase in the gross margin, which now stands at 39.2%. Additionally, the operating margin improved by 230 basis points, reaching 17.6%. Surpassing all predictions, Badger Meter reported an EPS of $0.84, exceeding the consensus of $0.82.

Despite these impressive financial results, BMI shares experienced a 7.16% decline, trading at $141.41 as of the last check on Friday. However, this setback does not overshadow the company’s overall success. Badger Meter’s strong performance can be attributed to its focus on providing innovative and differentiated technologies, driving operational excellence, and maintaining a resilient order pace. Moreover, the robust bid funnel and backlog further instill confidence in the company’s ability to achieve continuous sales and earnings growth year after year.

It is worth noting that Badger Meter’s positive momentum extends beyond the fourth quarter. Over the past year, the company’s shares have gained an impressive 30.7%, outperforming the growth of its sub-industry, which stood at 13%. Looking ahead, analysts predict a 35.8% increase in EPS for 2023 and a further 9.1% increase in 2024, reaching $3.07 and $3.20, respectively. This optimism is reflected in the Zacks Consensus Estimate for 2023 and 2024 earnings, which has seen a 7.3% and 8.1% increase, respectively, in the past 90 days.

Badger Meter’s success can be attributed to its focus on providing comprehensive water solutions, including flow measurement, quality assessment, and other system parameters. This commitment to excellence has been a driving force behind the company’s strong performance. Additionally, Badger Meter has implemented temporary cost-saving measures to ensure smooth operations and currently holds $162.9 million in cash and cash equivalents as of September 30, 2023.

In conclusion, Badger Meter’s impressive financial results in the fourth quarter of 2023, combined with its optimistic outlook for future growth, showcase the company’s triumph in providing innovative water solutions and driving operational excellence. Despite a temporary decrease in share price, Badger Meter remains steadfast in its commitment to delivering exceptional results and meeting market expectations.

Decline in BMI Stock Performance on January 27, 2024: Investors Monitor for Potential Recovery

BMI stock experienced a decline in performance on January 27, 2024. The stock was observed to be below its 200-day simple moving average and trading in the middle of its 52-week range, indicating a weak performance. The share price of BMI dropped by $8.55, representing a 5.61% decrease, and continued to decline in after-hours trading. This downward trend suggests a negative trajectory for the stock. Investors and analysts will closely monitor BMI’s performance to determine if this decline is temporary or a sustained trend. It is important to consider various factors, such as market conditions, company news, and investor sentiment, when analyzing stock performance. Overall, BMI’s stock faces challenges in gaining momentum and investors will be watching for a potential recovery.

Steady Performance of BMI Stock on January 27, 2024: Financial Results and Analysis

BMI Stock Shows Steady Performance on January 27, 2024

On January 27, 2024, BMI stock exhibited a stable performance, reflecting the company’s consistent financial results. The data, sourced from CNN Money, provides insight into BMI’s financial performance over the past year, with a particular focus on the fourth quarter.

Total revenue for BMI in the past year amounted to $703.59 million, showing a significant increase of 24.4% compared to the previous year. However, the total revenue remained flat in the fourth quarter, standing at $182.44 million.

Similarly, BMI’s net income demonstrated positive growth. Over the past year, the company’s net income reached $92.60 million, marking a substantial increase of 39.25% compared to the previous year. Like the total revenue, the net income held steady in the fourth quarter, amounting to $24.72 million.

Earnings per share (EPS) is an essential metric for investors, as it indicates the profitability of a company on a per-share basis. BMI’s EPS for the past year stood at $3.14, reflecting a significant increase of 38.72% compared to the previous year. However, the EPS experienced a slight decline in the fourth quarter, decreasing by 4.66% and amounting to $0.84.

Overall, BMI’s stock performance on January 27, 2024, suggests stability and consistent financial results. The company’s total revenue and net income demonstrated considerable growth over the past year, while maintaining a steady performance in the fourth quarter. Although the EPS experienced a minor decline in the final quarter, it remained at a healthy level. These indicators suggest that BMI is well-positioned in its industry and able to navigate market conditions effectively. Investors can view BMI as a reliable investment option based on its consistent financial performance.

Tags: BMI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Cash

Mixed Sentiment and Significant Interest in JDcom Options Trading

Finance_ Stock Charts (2)

JP Morgan Analyst Raises Price Target for Bread Finl Hldgs NYSEBFH

GD stock news

Financial Analysts Express Positive Sentiment Towards CVRx Stock

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com